Endoscopic treatment (endoscopic balloon dilation/self-expandable metal stent) vs surgical resection for the treatment of de novo stenosis in Crohn ’s disease (ENDOCIR study): an open-label, multicentre, randomized trial
DiscussionThe ENDOCIR trial has been designed to determine whether an endoscopic or surgical approach is therapeutically superior in the treatment of de novo stenosis in CD.Trial registrationClinicalTrials.gov NCT 04330846. Registered on 1 April 1 2020.https://clinicaltrials.gov/ct2/home (Source: Trials)
Source: Trials - June 27, 2023 Category: Research Source Type: clinical trials
RVT-3101 for the Treatment of Moderate to Severe Active Crohn's Disease
Condition: Crohn Disease Intervention: Drug: RVT-3101 Sponsor: Telavant, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 19, 2023 Category: Research Source Type: clinical trials
Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
Condition: Crohn Disease Intervention: Drug: Infliximab Sponsor: Taizhou Mabtech Pharmaceutical Co.,Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials
RVT-3101 for the Treatment of Moderate to Severe Active Crohn's Disease
Condition: Crohn Disease Intervention: Drug: RVT-3101 Sponsor: Telavant, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials
Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
Condition: Crohn Disease Intervention: Drug: Infliximab Sponsor: Taizhou Mabtech Pharmaceutical Co.,Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials
RVT-3101 for the Treatment of Moderate to Severe Active Crohn's Disease
Condition: Crohn Disease Intervention: Drug: RVT-3101 Sponsor: Telavant, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials
Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
Condition: Crohn Disease Intervention: Drug: Infliximab Sponsor: Taizhou Mabtech Pharmaceutical Co.,Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials
RVT-3101 for the Treatment of Moderate to Severe Active Crohn's Disease
Condition: Crohn Disease Intervention: Drug: RVT-3101 Sponsor: Telavant, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials
Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
Condition: Crohn Disease Intervention: Drug: Infliximab Sponsor: Taizhou Mabtech Pharmaceutical Co.,Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials
